Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

U J Kang

Showing results (1-10 of 37) with videos related to

Pageof 4
Sort By:
Movement Disorders : Official Journal of the Movement Disorder Society|June 5, 1998
Potential of gene therapy for Parkinson's disease: neurobiologic issues and new developments in gene transfer methodologiesU J Kang
Rational Drug Therapy|August 1, 1988
Management of tardive dyskinesiaU J Kang, S Fahn
Brain Research. Molecular Brain Research|June 1, 1990
Deduced amino acid sequence of bovine aromatic L-amino acid decarboxylase: homology to other decarboxylasesU J Kang, T H Joh
Advances in Neurology|January 1, 1988
Tardive dystonia: clinical aspects and treatmentR E Burke, U J Kang
Journal of Neurochemistry|February 12, 1998
The role of glutathione in dopaminergic neuronal survivalK Nakamura, W Wang, U J Kang
Movement Disorders : Official Journal of the Movement Disorder Society|March 1, 1995
Spread of symptoms in idiopathic torsion dystoniaP Greene, U J Kang, S Fahn
Journal of Neurochemistry|February 12, 1998
Role of aromatic L-amino acid decarboxylase for dopamine replacement by genetically modified fibroblasts in a rat model of Parkinson's diseaseS R Wachtel, C Bencsics, U J Kang
Movement Disorders : Official Journal of the Movement Disorder Society|January 1, 1986
Natural history and treatment of tardive dystoniaU J Kang, R E Burke, S Fahn
Advances in Neurology|January 1, 1988
Tardive dystoniaU J Kang, R E Burke, S Fahn
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|December 1, 1995
Intrastriatal implantation of fibroblasts genetically engineered to produce brain-derived neurotrophic factor prevents degeneration of dopaminergic neurons in a rat model of Parkinson's diseaseM Levivier, S Przedborski, C Bencsics, et al.
Pageof 4

Showing results (1-10 of 37) with videos related to

Sort By:
Pageof 4
Movement Disorders : Official Journal of the Movement Disorder Society|June 5, 1998
Potential of gene therapy for Parkinson's disease: neurobiologic issues and new developments in gene transfer methodologiesU J Kang
Rational Drug Therapy|August 1, 1988
Management of tardive dyskinesiaU J Kang, S Fahn
Brain Research. Molecular Brain Research|June 1, 1990
Deduced amino acid sequence of bovine aromatic L-amino acid decarboxylase: homology to other decarboxylasesU J Kang, T H Joh
Advances in Neurology|January 1, 1988
Tardive dystonia: clinical aspects and treatmentR E Burke, U J Kang
Journal of Neurochemistry|February 12, 1998
The role of glutathione in dopaminergic neuronal survivalK Nakamura, W Wang, U J Kang
Movement Disorders : Official Journal of the Movement Disorder Society|March 1, 1995
Spread of symptoms in idiopathic torsion dystoniaP Greene, U J Kang, S Fahn
Journal of Neurochemistry|February 12, 1998
Role of aromatic L-amino acid decarboxylase for dopamine replacement by genetically modified fibroblasts in a rat model of Parkinson's diseaseS R Wachtel, C Bencsics, U J Kang
Movement Disorders : Official Journal of the Movement Disorder Society|January 1, 1986
Natural history and treatment of tardive dystoniaU J Kang, R E Burke, S Fahn
Advances in Neurology|January 1, 1988
Tardive dystoniaU J Kang, R E Burke, S Fahn
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|December 1, 1995
Intrastriatal implantation of fibroblasts genetically engineered to produce brain-derived neurotrophic factor prevents degeneration of dopaminergic neurons in a rat model of Parkinson's diseaseM Levivier, S Przedborski, C Bencsics, et al.
Pageof 4